The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

OPPORTUNITY IN MISSILE DEFENSE STOCKS, ONCE IN A CENTURY BUYING STAMPEDE IN HONG KONG

October 2, 2024

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. The Power Of Missile Defense Please click here for a chart of RTX Corporation stock (RTX). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of RTX stock is being used to illustrate the point. Yesterday, Iran fired about 180 ballistic missiles on Israel.  Israel and the U.S. were able to intercept most of these missiles with missile defense systems.  These missiles reached Israel in 12 minutes.  The defense was impressive considering there were no

Read More »

POWELL STOCK MARKET DIP AGGRESSIVELY BOUGHT, IMPORTANT DATA AND BLIND MONEY AHEAD

October 1, 2024

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Important Data Ahead Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the dip in the market caused by Powell’s remarks.  Powell pushed back against aggressive rate cut bets that the momo crowd has placed.  Powell clearly said that the Fed plans on two 25 bps cuts this year assuming the economy stays on the expected trajectory.  The momo crowd is counting on 100 bps

Read More »

FOMO DRIVES BIGGEST GAIN IN SHANGHAI SINCE 2008, CHINESE MARKET BREAKS THE NEGATIVE PATTERN

September 30, 2024

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Chinese Market Breaks Negative Pattern Please click here for a chart of Mainland China ETF (ASHR). Note the following: In prior Morning Capsules, we shared with you details of China’s stimulus program.  Prior to last Tuesday, Chinese stocks had been beaten down and had been trading at low valuations. The chart shows that the Chinese stock market has broken the negative pattern of lower highs. The chart shows that the pattern existed from the 2021 peak until last week. When the rally first

Read More »

WEEKLY STOCK MARKET DIGEST: PRUDENT INVESTORS PAY CLOSE ATTENTION TO GLOBAL EVENTS AND THEIR IMPACT ON THE STOCK MARKET

September 28, 2024

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section ‘Protection Bands and What To Do Now.’   PERSONAL INCOME AND SPENDING DISAPPOINT, SUPER MICRO COMPUTER LESSON, BOJ SUPPORTER AS JAPAN PM Sep

Read More »

PERSONAL INCOME AND SPENDING DISAPPOINT, SUPER MICRO COMPUTER LESSON, BOJ SUPPORTER AS JAPAN PM

September 27, 2024

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Spending Disappointment Please click here for a chart of Super Micro Computer stock (SMCI). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of SMCI stock is being used to illustrate the point. A fortune is to be made in artificial intelligence, but it is not going to be in a straight line.  At times, it is going to be treacherous.  It is important to not make mistakes by getting carried away with the momo

Read More »

CHINA BAZOOKA BRINGS OPTIMISM TO U.S. STOCKS, MICRON EARNINGS SHOW THE VALUE OF KNOWING POSITIONING

September 26, 2024

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Growing Optimism Please click here for a chart of Micron stock (MU). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of MU stock is being used to illustrate the point. In yesterday’s Morning Capsule, we wrote the following about Micron earnings in advance: Going into earnings, here are the key points: Whisper numbers are below the consensus numbers.  This is an oddity among AI stocks.  Among AI stocks, whisper numbers have consistently been higher

Read More »

HERE IS WHERE TO MAKE THE NEXT FORTUNE IN AI

September 25, 2024

By Nigam Arora & Dr. Natasha Arora Do you want to know where to make the next fortune in AI?  Listen to this interview of Nigam Arora by Oliver Renick of Schwab Network. Click here to watch the interview. To take a free 30-day trial to paid services to gain access to more opportunities, please click here.   Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY

Read More »

OPPORTUNITY IN BIOTECH WITHIN BUYOUT POTENTIAL BEATING GOLD STANDARD IN LUNG CANCER TREATMENT

September 25, 2024

By Nigam Arora & Dr. Natasha Arora Better Than Gold Standard In a Phase 3 study, Summit Therapeutics Inc’s (SMMT) drug showed a statistically significant 5.3 months of improvement in progression free survival versus Keytruda in treatment of PD-L1- positive advanced non-small cell lung cancer.  Keytruda from MRK is the gold standard. Buyout Target SMMT has also become a buyout target.  To date 196 Arora portfolio companies have been bought out, producing a fortune for members who consistently invest in buyouts. MRK Has Blazed The Trail MRK has already blazed the trail by getting approval for Keytruda for a number of cancers. 

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content